Follow sponsors and diseases. See every trial change in one daily digest.
Follow sponsors, diseases, or individual trials. We flag terminations, pushed dates, cut enrollment, and changed endpoints on ClinicalTrials.gov.
Try: Pfizer · Obesity · NCT04133636
Your daily digest, for example
From the last 7 days- Stopped: SSGJ-707 in Advanced Non-Small Cell Lung Cancer Trial terminated
- Notable: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans Enrollment reduced: 30 → 10 participants
- Notable: BREATHE · Boosting Resources for Tracheostomy Care at Home Enrollment reduced: 480 → 330 participants
Delivered by email each morning, or weekly if you prefer.
This week on ClinicalTrials.gov
Changes detected in the 7 days to Nov 19, 2026- Stopped: SSGJ-707 in Advanced Non-Small Cell Lung Cancer Trial terminated
- Stopped: WONDERS1 · Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy · HIV-1 Who Are Virologically Suppressed Trial terminated
- Stopped: X-NOVA2 · Azetukalner Versus Placebo in Major Depressive Disorder Trial terminated
- Stopped: Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD) Withdrawn before enrolling
- Stopped: AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix Trial terminated
- Notable: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans Enrollment reduced: 30 → 10 participants
- Notable: BREATHE · Boosting Resources for Tracheostomy Care at Home Enrollment reduced: 480 → 330 participants
- Notable: Correlation of Pelvic Sentinel Lymph Node With Superficial Vein Enrollment reduced: 100 → 50 participants
- Notable: IMEDESCAL · Baropodometric Patterns Associated With Metatarsalgia Enrollment reduced: 180 → 120 participants
- Notable: Prevelance of Uterine Vein and Uterine Vein System Variations Enrollment reduced: 100 → 50 participants
- Minor: COVID-19 Vaccine(s) in Children and Adults Enrollment closed, study ongoing
- Minor: Depemokimab Compared With Mepolizumab · Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial completed
- Minor: AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) · Anemia Enrollment closed, study ongoing
- Minor: PF-06821497 (Mevrometostat) Works · Metastatic Castration-resistant Prostate Cancer Enrollment closed, study ongoing
- Minor: Balcinrenone/Dapagliflozin · Heart Failure and Impaired Kidney Function Enrollment closed, study ongoing
- Stopped: SSGJ-707 in Advanced Non-Small Cell Lung Cancer Trial terminated
- Stopped: WONDERS1 · Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy · HIV-1 Who Are Virologically Suppressed Trial terminated
- Stopped: X-NOVA2 · Azetukalner Versus Placebo in Major Depressive Disorder Trial terminated
- Stopped: Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD) Withdrawn before enrolling
- Stopped: AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix Trial terminated
Built for people who watch pipelines
Daily watchlist digest
Follow a sponsor, a disease, or a single trial. Get an email with exactly what changed in the record.
At Risk Pro
Watched trials with pushed dates, cut enrollment, or changed endpoints, ranked so you see the worst first.
Pipeline Pulse
88 disease areas ranked by momentum.
Start with one sponsor or disease.
Free to start. Upgrade for At Risk and Completions.